Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 53 (RPL21P53)

Target
RPL21P53
Molecular classification
Other (processed pseudogene; related to ribosomal protein genes)
01

Overview

RPL21P53 is a processed pseudogene related to the human RPL21 gene, which encodes 60S ribosomal protein L21, a structural component of the cytoplasmic ribosome. Pseudogenes like RPL21P53 arise from duplication or retrotransposition events and do not produce functional proteins. While ribosomal protein pseudogene expression may be dysregulated in some diseases and could reflect cell proliferation or stress (as reported for similar pseudogenes), there is no evidence that RPL21P53 itself functions as a therapeutic target or biomarker. Some ribosomal protein pseudogenes may affect gene regulation, but their roles are often speculative and not well characterized. RPL21P53 is not a canonical target for drug development as it does not encode a functional ribosomal protein or receptor. The name and abbreviation are correctly formatted, but the molecule is often confused with its protein-coding parent gene, RPL21; this is an important distinction for structured database curation. If you need information on the functional ribosomal protein itself, refer to RPL21 (ribosomal protein L21), which is protein-coding and associated with ribosome structure and certain genetic diseases.

Other names
RPL21_19_517RPL21P53
02

Biological functions

Other (no direct biological function; may have minor regulatory or RNA-level effects, but does not encode a protein)
03

Disease associations

Other (no direct role; parent gene RPL21 is associated with Hypotrichosis simplex of the scalp and some ribosomal protein pseudogenes show altered expression in diseases such as depression, but no direct evidence for RPL21P53)

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 53 (RPL21P53).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 53 (RPL21P53).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call